Evidence map›Paper›PMID 38813981›Full record

ArticleBioscience reports2024

Atox1-cyclin D1 loop activity is critical for survival of tumor cells with inactivated TP53.

Oleg A Kuchur, Sofya S Pogodaeva, Anna V Shcherbakova, Segrey A Tsymbal

Abstract read
In one paragraph

Article in Bioscience reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oleg A KuchurNational Research University ITMO, 197101 St. Petersburg, Russia.ORCID 0000-0002-3700-4131
Sofya S PogodaevaNational Research University ITMO, 197101 St. Petersburg, Russia.
Anna V ShcherbakovaNational Research University ITMO, 197101 St. Petersburg, Russia.
Segrey A TsymbalNational Research University ITMO, 197101 St. Petersburg, Russia.

Funding

Russian Science Foundation (RSF) 22-24-00588
6 · The paper itself

Abstract

The search for relevant molecular targets is one of the main tasks of modern tumor chemotherapy. To successfully achieve this, it is necessary to have the most complete understanding of the functioning of a transcriptional apparatus of the cell, particularly related to proliferation. The p53 protein plays an important role in regulating processes such as apoptosis, repair, and cell division, and the loss of its functionality often accompanies various types of tumors and contributes to the development of chemoresistance. Additionally, the proliferative activity of tumor cells is closely related to the metabolism of transition metals. For example, the metallochaperone Atox1 - a copper transporter protein - acts as a transcription activator for cyclin D1, promoting progression through the G1/S phase of the cell cycle. On the other hand, p53 suppresses cyclin D1 at the transcriptional level, thereby these proteins have divergent effects on cell cycle progression. However, the contribution of the interaction between these proteins to cell survival is poorly understood. This work demonstrates that not only exists a positive feedback loop between Atox1 and cyclin D1 but also that the activity of this loop depends on the status of the TP53 gene. Upon inactivation of TP53 in A549 and HepG2 cell lines, the expression of ATOX1 and CCND1 genes is enhanced, and their suppression in these cells leads to pronounced apoptosis. This fundamental observation may be useful in selecting more precise interventions for combined therapy of p53-negative tumors.

Indexed as

Cell SurvivalCopper Transport ProteinsCyclin D1Tumor Suppressor Protein p53A549 CellsApoptosisCation Transport ProteinsCell ProliferationGene Expression Regulation, NeoplasticHep G2 CellsHumansMetallochaperonesMolecular ChaperonesATOX1 protein, humanCation Transport ProteinsCCND1 protein, humanCopper Transport ProteinsCyclin D1MetallochaperonesMolecular ChaperonesTP53 protein, humanTumor Suppressor Protein p53ATOX1cell deathCyclin D1eukaryotic gene expressionp53synthetic lethality

Identifiers

PMID38813981
PMCPMC11166628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.